140 related articles for article (PubMed ID: 36007979)
1. Antibodies to FXa and thrombin in patients with SLE differentially regulate C3 and C5 cleavage.
McDonnell T; Amarnani R; Spicer C; Jbari H; Pericleous C; Spiteri VA; Wincup C; Artim-Esen B; Mackie I; Botto M; Rahman A; Giles I
Lupus Sci Med; 2022 Aug; 9(1):. PubMed ID: 36007979
[TBL] [Abstract][Full Text] [Related]
2. Anti-factor Xa antibodies in patients with antiphospholipid syndrome and their effects upon coagulation assays.
Artim-Esen B; Pericleous C; Mackie I; Ripoll VM; Latchman D; Isenberg D; Rahman A; Ioannou Y; Giles I
Arthritis Res Ther; 2015 Mar; 17(1):47. PubMed ID: 25890027
[TBL] [Abstract][Full Text] [Related]
3. Clinical performance of antibodies to prothrombin and thrombin in Chinese patients with antiphospholipid syndrome: potential interest in discriminating patients with thrombotic events and non-thrombotic events.
Zhang S; Wu Z; Li J; Li P; Chen S; Wen X; Li L; Zhang W; Zhao J; Zhang F; Li Y
Rheumatol Int; 2017 Apr; 37(4):579-584. PubMed ID: 27807637
[TBL] [Abstract][Full Text] [Related]
4. Factor Xa Mediates Calcium Flux in Endothelial Cells and is Potentiated by Igg From Patients With Lupus and/or Antiphospholipid Syndrome.
Artim-Esen B; Smoktunowicz N; McDonnell T; Ripoll VM; Pericleous C; Mackie I; Robinson E; Isenberg D; Rahman A; Ioannou Y; Chambers RC; Giles I
Sci Rep; 2017 Sep; 7(1):10788. PubMed ID: 28883515
[TBL] [Abstract][Full Text] [Related]
5. Antibodies against the activated coagulation factor X (FXa) in the antiphospholipid syndrome that interfere with the FXa inactivation by antithrombin.
Yang YH; Hwang KK; FitzGerald J; Grossman JM; Taylor M; Hahn BH; Chen PP
J Immunol; 2006 Dec; 177(11):8219-25. PubMed ID: 17114499
[TBL] [Abstract][Full Text] [Related]
6. Opposite Profiles of Complement in Antiphospholipid Syndrome (APS) and Systemic Lupus Erythematosus (SLE) Among Patients With Antiphospholipid Antibodies (aPL).
Savelli SL; Roubey RAS; Kitzmiller KJ; Zhou D; Nagaraja HN; Mulvihill E; Barbar-Smiley F; Ardoin SP; Wu YL; Yu CY
Front Immunol; 2019; 10():885. PubMed ID: 31134052
[TBL] [Abstract][Full Text] [Related]
7. Sole existence of antithrombin antibody in patients with systemic lupus erythematosus showing tendency of its antigenic determinants directing against exosite II (antithrombin/heparin binding site) of thrombin.
Matsuda J; Matsuyama A; Atsumi G; Ohkura N
Blood Coagul Fibrinolysis; 2008 Jan; 19(1):66-9. PubMed ID: 18180618
[TBL] [Abstract][Full Text] [Related]
8. Anti-beta2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome.
Inanç M; Donohoe S; Ravirajan CT; Radway-Bright EL; Mackie I; Machin S; Isenberg DA
Br J Rheumatol; 1998 Oct; 37(10):1089-94. PubMed ID: 9825748
[TBL] [Abstract][Full Text] [Related]
9. Antibodies to Domain I β
Reshetnyak TM; Cheldieva FA; Cherkasova MV; Glukhova SI; Lila AM; Nasonov EL
Dokl Biochem Biophys; 2023 Aug; 511(1):219-226. PubMed ID: 37833609
[TBL] [Abstract][Full Text] [Related]
10. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
11. Interactions of human monoclonal and polyclonal antiphospholipid antibodies with serine proteases involved in hemostasis.
Lambrianides A; Turner-Stokes T; Pericleous C; Ehsanullah J; Papadimitraki E; Poulton K; Ioannou Y; Lawrie A; Mackie I; Chen P; Latchman D; Isenberg D; Rahman A; Giles I
Arthritis Rheum; 2011 Nov; 63(11):3512-21. PubMed ID: 21739425
[TBL] [Abstract][Full Text] [Related]
12. Extended Antiphospholipid Antibodies Screening in Systemic Lupus Erythematosus Patients.
Dima A; Caraiola S; Jurcut C; Balanescu E; Balanescu P; Ramba D; Badea C; Pompilian V; Ionescu R; Baicus A; Baicus C; Dan GA
Rom J Intern Med; 2015; 53(4):321-8. PubMed ID: 26939208
[TBL] [Abstract][Full Text] [Related]
13. Hypocomplementemia in systemic lupus erythematosus and primary antiphospholipid syndrome: prevalence and clinical significance in 667 patients.
Ramos-Casals M; Campoamor MT; Chamorro A; Salvador G; Segura S; Botero JC; Yagüe J; Cervera R; Ingelmo M; Font J
Lupus; 2004; 13(10):777-83. PubMed ID: 15540510
[TBL] [Abstract][Full Text] [Related]
14. Autoantibodies against C-reactive protein: clinical associations in systemic lupus erythematosus and primary antiphospholipid syndrome.
Figueredo MA; Rodriguez A; Ruiz-Yagüe M; Romero M; Fernandez-Cruz A; Gomez-de la Concha E; Patiño R
J Rheumatol; 2006 Oct; 33(10):1980-6. PubMed ID: 17014014
[TBL] [Abstract][Full Text] [Related]
15. Anti-β2GPI-domain I antibody is associated with extra-criteria manifestations in a large prospective antiphospholipid syndrome cohort in China.
Zhou Y; Hu C; Qi W; Long Y; Huang C; Wang Q; Tian X; Zhao J; Li M; Zeng X
Lupus Sci Med; 2023 Aug; 10(2):. PubMed ID: 37607781
[TBL] [Abstract][Full Text] [Related]
16. Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome.
Alpert D; Mandl LA; Erkan D; Yin W; Peerschke EI; Salmon JE
Ann Rheum Dis; 2008 Mar; 67(3):395-401. PubMed ID: 17644539
[TBL] [Abstract][Full Text] [Related]
17. IgA Antiphospholipid Antibodies in Antiphospholipid Syndrome and Systemic Lupus Erythematosus.
Reshetnyak T; Cheldieva F; Cherkasova M; Lila A; Nasonov E
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012697
[TBL] [Abstract][Full Text] [Related]
18. IgG anti-beta(2) glycoprotein I antibodies in Malaysian patients with antiphospholipid syndrome and systemic lupus erythematosus: prevalence and clinical correlations.
Ong SG; Cheng HM; Soon SC; Goh E; Chow SK; Yeap SS
Clin Rheumatol; 2002 Sep; 21(5):382-5. PubMed ID: 12223986
[TBL] [Abstract][Full Text] [Related]
19. OxLDL/beta2GPI complexes and autoantibodies in patients with systemic lupus erythematosus, systemic sclerosis, and antiphospholipid syndrome: pathogenic implications for vascular involvement.
Lopez LR; Simpson DF; Hurley BL; Matsuura E
Ann N Y Acad Sci; 2005 Jun; 1051():313-22. PubMed ID: 16126973
[TBL] [Abstract][Full Text] [Related]
20. Novel autoantibodies against the activated coagulation factor IX (FIXa) in the antiphospholipid syndrome that interpose the FIXa regulation by antithrombin.
Yang YH; Chien D; Wu M; FitzGerald J; Grossman JM; Hahn BH; Hwang KK; Chen PP
J Immunol; 2009 Feb; 182(3):1674-80. PubMed ID: 19155517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
